11/7/2022 0 Comments Syn stock news![]() ![]() Kaival Brands Innovations recently announced the U.S. (NASDAQ: KAVL ) surged 51.4% to settle at $1.62. (NASDAQ: ANGH ) shares climbed 62.5% to close at $19.50 following its recent listing on NASDAQ. The company, on Friday, priced its IPO at $5 per share. (NASDAQ: NVCT ) shares surged 144.6% to close at $7.95 on Monday. Read moreĤ7 Biggest Movers From Yesterday 09:53am, Tuesday, 08'th Feb 2022 Benzinga ![]() "According to the latest research study, the demand of global Irritable Bowel Syndrome (IBS) Diagnostics Market size & share was valued at approximately USD 1.2 Billion in 2020 and is expected to reach a value of around USD 2.3 Billion by 2026, at a compound annual growth rate (CAGR) of about 9.7% during the forecast period 2021 to 2026." What is Irritable Bowel Syndrome (IBS) Diagnostics? How big is the Irritable Bowel Syndrome (IBS) Diagnostics Market? Market Overview & Coverage: Irritable bowel syndrome is a medical condition that pertains to irregular bowel movement and is accompanied by extreme pain in the stomach followed by diarrhoea, cramping, and constipation among others. 14, 2022 (GLOBE NEWSWIRE) - Facts and Factors has published a new research report titled "Irritable Bowel Syndrome (IBS) Diagnostics Market By Type (IBS-C, IBS-D and Mixed IBS), By Product (Rifaximin, Eluxadoline, Lubiprostone, Linaclotide, & Others), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, & Online Pharmacies), and By Regions Global & Regional Industry Perspective, Comprehensive Analysis, and Forecast, 2021 2026" in its research database. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size is expected +9.7% CAGR Growth, Will Hit US$ 2.3 Billion by 2026 | Industry Trends & Forecast by Facts & Factors 03:29pm, Monday, 14'th Feb 2022 Benzinga ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |